Zimmer Biomet

Yahoo Finance • 2 days ago

Robotic Neurosurgery Market Analysis and Forecast Report 2025-2035, with Profiles of Brainlab, Renishaw, Zimmer Biomet, Medical Microinstruments, Monteris Medical, Medtronic, Globus Medical, & Accuray

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Robotic Neurosurgery Market - A Global and Regional Analysis: Focus on Application, Product Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added t... Full story

Yahoo Finance • 6 days ago

EU MedTech stocks down as U.S. launches national security probe into imports

[A magnifying glass placed in the scattered wooden letters] patpitchaya/iStock via Getty Images European MedTech stocks were trading lower on Thursday after the U.S. Department of Commerce launched a new national security investigation in... Full story

Yahoo Finance • 11 days ago

Does Zimmer Biomet’s Raised Guidance and Lower Tariff Headwinds Strengthen the Bull Case for ZBH?

Zimmer Biomet reported better-than-expected Q2 2025 results, with revenues of US$2.08 billion and adjusted EPS of US$2.07, leading management to raise full-year forecasted adjusted EPS to US$8.10–US$8.30 and reduce its anticipated tariff h... Full story

Yahoo Finance • 13 days ago

Target initiated, Nike upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: RBC Capital upgraded Nike (NKE) to Out... Full story

Yahoo Finance • 21 days ago

Zimmer Biomet Holdings (ZBH) Fell due to Reduced Guidance

Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The Russell Midcap Index posted positive returns... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Novo Nordisk, Medtronic, Novavax in focus

Wall Street jumped sharply on Friday, with the Dow hitting a fresh all-time high as investors welcomed Federal Reserve Chair Jerome Powell’s remarks at Jackson Hole. The S&P 500 Health Care Index Sector (NYSEARCA:XLV [https://seekingalpha... Full story

Yahoo Finance • last month

Global Surgical Sutures Market Poised to Reach USD 6.65 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The global surgical sutures market, valued at US$4.56 billion in 2024, stood at US$4.84 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culmin... Full story

Yahoo Finance • last month

Dental CAD-CAM Market Forecast and Company Analysis Report 2025-2029, with 3Shape, Align Technology, Carestream Dental, Dentsply Sirona, Jensen Dental, Schutz Dental, and Yenadent

Dublin, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The "Dental CAD-CAM Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The dental CAD-CAM market is projected to expand significantly, with an anticipated growth of USD 978.... Full story

Yahoo Finance • 2 months ago

Zimmer (ZBH) Builds Robotics Growth Pipeline, but BofA Sees Limited Near-Term Upside

Zimmer Biomet Holdings Inc. (NYSE:ZBH) is one of the best defensive stocks to invest in according to analysts. With a decline of around 14%, Zimmer’s YTD share price performance has been weak. Its management is focussing on reinvigorating... Full story

Yahoo Finance • 2 months ago

Bernstein raises Zimmer Biomet stock price target to $105 on improving outlook

Investing.com - Bernstein SocGen Group raised its price target on Zimmer Biomet (NYSE:ZBH) to $105.00 from $100.00 on Friday, while maintaining a Market Perform rating on the medical device maker’s stock. The company, with a market capital... Full story

Yahoo Finance • 2 months ago

Zimmer Biomet raises annual profit forecast on strong demand for medical devices

(Reuters) -Zimmer Biomet Holdings raised its full-year adjusted profit forecast and beat second-quarter earnings expectations on Thursday, bolstered by accelerating demand for its hip and knee implants. Medical device makers have benefite... Full story

Yahoo Finance • 2 months ago

Zimmer Biomet Non-GAAP EPS of $2.07 beats by $0.09, revenue of $2.08B beats by $20M

* Zimmer Biomet press release [https://seekingalpha.com/pr/20192667-zimmer-biomet-announces-second-quarter-2025-financial-results] (NYSE:ZBH [https://seekingalpha.com/symbol/ZBH]): Q2 Non-GAAP EPS of $2.07 beats by $0.09. * Revenue of... Full story

Yahoo Finance • 2 months ago

Zimmer Biomet Holdings Inc (NYSE:ZBH): A Steady Dividend Performer with Strong Profitability and Financial Stability

When assessing stocks for dividend investing, a measured strategy is important. The "Best Dividend Stocks" screen finds companies with good dividend traits while keeping steady profitability and financial strength, key elements in maintain... Full story

Yahoo Finance • 2 months ago

Zimmer Biomet Holdings, Inc. (ZBH): A Bull Case Theory

We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on Valueinvesting subreddit by KnowledgePatient7813. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.'s share was trading at $97.55 as... Full story

Yahoo Finance • 2 months ago

Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery

The Procedure Utilized Monogram’s mBôs TKA System Performed in India with Shalby Hospitals Groundbreaking Procedure Delivers the World’s First Autonomous Saw-Based Robotic TKA Surgery on a Live Patient AUSTIN, Texas, July 29, 2025 (GLO... Full story

Yahoo Finance • 2 months ago

North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace

Company Logo The North America Clinical Trials Market is projected to grow from US$ 20.07 billion in 2024 to US$ 33.91 billion by 2033, registering a CAGR of 6.00% from 2025 to 2033. Key drivers include the increasing demand for novel tre... Full story

Yahoo Finance • 2 months ago

Zimmer Biomet Holdings Inc (NYSE:ZBH): A Prime Value Investing Opportunity with Strong Fundamentals and Undervalued Metrics

Value investing focuses on finding stocks priced below their true worth while keeping strong financial foundations—a method introduced by Benjamin Graham and improved by Warren Buffett. This strategy looks for companies with good earnings,... Full story

Yahoo Finance • 2 months ago

Zimmer Biomet's SWOT analysis: stock faces challenges amid strategic acquisitions

Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices industry, has been making strategic moves to strengthen its market position and expand its product portfolio. With an "GREAT" financial health score according t... Full story

Yahoo Finance • 3 months ago

What Makes Zimmer Biomet Holdings (ZBH) an Investment Opportunity?

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. The equity portfolio returned 4.67% in the second quarter compared to 10.94% f... Full story

Yahoo Finance • 3 months ago

Peter Lynch Detailed Fundamental Analysis - ZBH

Below is Validea's guru fundamental report for ZIMMER BIOMET HOLDINGS INC (ZBH). Of the 22 guru strategies we follow, ZBH rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy look... Full story